56 research outputs found

    Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies

    Get PDF
    The role that mechanistic mathematical modeling and systems biology will play in molecular medicine and clinical development remains uncertain. In this study, mathematical modeling and sensitivity analysis were used to explore the working hypothesis that mechanistic models of human cascades, despite model uncertainty, can be computationally screened for points of fragility, and that these sensitive mechanisms could serve as therapeutic targets. We tested our working hypothesis by screening a model of the well-studied coagulation cascade, developed and validated from literature. The predicted sensitive mechanisms were then compared with the treatment literature. The model, composed of 92 proteins and 148 protein–protein interactions, was validated using 21 published datasets generated from two different quiescent in vitro coagulation models. Simulated platelet activation and thrombin generation profiles in the presence and absence of natural anticoagulants were consistent with measured values, with a mean correlation of 0.87 across all trials. Overall state sensitivity coefficients, which measure the robustness or fragility of a given mechanism, were calculated using a Monte Carlo strategy. In the absence of anticoagulants, fluid and surface phase factor X/activated factor X (fX/FXa) activity and thrombin-mediated platelet activation were found to be fragile, while fIX/FIXa and fVIII/FVIIIa activation and activity were robust. Both anti-fX/FXa and direct thrombin inhibitors are important classes of anticoagulants; for example, anti-fX/FXa inhibitors have FDA approval for the prevention of venous thromboembolism following surgical intervention and as an initial treatment for deep venous thrombosis and pulmonary embolism. Both in vitro and in vivo experimental evidence is reviewed supporting the prediction that fIX/FIXa activity is robust. When taken together, these results support our working hypothesis that computationally derived points of fragility of human relevant cascades could be used as a rational basis for target selection despite model uncertainty

    A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials

    Get PDF
    Robustness, a long-recognized property of living systems, allows function in the face of uncertainty while fragility, i.e., extreme sensitivity, can potentially lead to catastrophic failure following seemingly innocuous perturbations. Carlson and Doyle hypothesized that highly-evolved networks, e.g., those involved in cell-cycle regulation, can be resistant to some perturbations while highly sensitive to others. The “robust yet fragile” duality of networks has been termed Highly Optimized Tolerance (HOT) and has been the basis of new lines of inquiry in computational and experimental biology. In this study, we tested the working hypothesis that cell-cycle control architectures obey the HOT paradigm. Three cell-cycle models were analyzed using monte-carlo sensitivity analysis. Overall state sensitivity coefficients, which quantify the robustness or fragility of a given mechanism, were calculated using a monte-carlo strategy with three different numerical techniques along with multiple parameter perturbation strategies to control for possible numerical and sampling artifacts. Approximately 65% of the mechanisms in the G1/S restriction point were responsible for 95% of the sensitivity, conversely, the G2-DNA damage checkpoint showed a much stronger dependence on a few mechanisms; ∼32% or 13 of 40 mechanisms accounted for 95% of the sensitivity. Our analysis predicted that CDC25 and cyclin E mechanisms were strongly implicated in G1/S malfunctions, while fragility in the G2/M checkpoint was predicted to be associated with the regulation of the cyclin B-CDK1 complex. Analysis of a third model containing both G1/S and G2/M checkpoint logic, predicted in addition to mechanisms already mentioned, that translation and programmed proteolysis were also key fragile subsystems. Comparison of the predicted fragile mechanisms with literature and current preclinical and clinical trials suggested a strong correlation between efficacy and fragility. Thus, when taken together, these results support the working hypothesis that cell-cycle control architectures are HOT networks and establish the mathematical estimation and subsequent therapeutic exploitation of fragile mechanisms as a novel strategy for anti-cancer lead generation

    Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke

    Get PDF
    Importance It is uncertain whether intravenous methylprednisolone improves outcomes for patients with acute ischemic stroke due to large-vessel occlusion (LVO) undergoing endovascular thrombectomy. Objective To assess the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO. Design, Setting, and Participants This investigator-initiated, randomized, double-blind, placebo-controlled trial was implemented at 82 hospitals in China, enrolling 1680 patients with stroke and proximal intracranial LVO presenting within 24 hours of time last known to be well. Recruitment took place between February 9, 2022, and June 30, 2023, with a final follow-up on September 30, 2023.InterventionsEligible patients were randomly assigned to intravenous methylprednisolone (n = 839) at 2 mg/kg/d or placebo (n = 841) for 3 days adjunctive to endovascular thrombectomy. Main Outcomes and Measures The primary efficacy outcome was disability level at 90 days as measured by the overall distribution of the modified Rankin Scale scores (range, 0 [no symptoms] to 6 [death]). The primary safety outcomes included mortality at 90 days and the incidence of symptomatic intracranial hemorrhage within 48 hours. Results Among 1680 patients randomized (median age, 69 years; 727 female [43.3%]), 1673 (99.6%) completed the trial. The median 90-day modified Rankin Scale score was 3 (IQR, 1-5) in the methylprednisolone group vs 3 (IQR, 1-6) in the placebo group (adjusted generalized odds ratio for a lower level of disability, 1.10 [95% CI, 0.96-1.25]; P = .17). In the methylprednisolone group, there was a lower mortality rate (23.2% vs 28.5%; adjusted risk ratio, 0.84 [95% CI, 0.71-0.98]; P = .03) and a lower rate of symptomatic intracranial hemorrhage (8.6% vs 11.7%; adjusted risk ratio, 0.74 [95% CI, 0.55-0.99]; P = .04) compared with placebo. Conclusions and Relevance Among patients with acute ischemic stroke due to LVO undergoing endovascular thrombectomy, adjunctive methylprednisolone added to endovascular thrombectomy did not significantly improve the degree of overall disability.Trial RegistrationChiCTR.org.cn Identifier: ChiCTR210005172

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Computational Modeling And Simulation Of Thrombus Formation

    Full text link
    Thrombosis is a serious medical complication because excessive thrombus formation could lead to obstruction of blood vessels, resulting in tissue ischemia or death. This study is aimed to understand the cell-biology and biophysics, at the molecular level, of thrombosis in a blood vessel. We first review the biology underlying thrombosis and the previous mathematical models of thrombus formation (Chapter 1). In Chapter 2, mathematical modeling and sensitivity analysis were used to explore the mechanistic model of thrombus formation; the results support our working hypothesis that computationally derived points of fragility of human relevant cascades could be used as a rational basis for target selection despite model uncertainty. Chapter 3 focuses on the impact of parametric sampling strategies of Monte-Carlo sensitivity analysis and network structural uncertainty upon the assessment of the qualitative importance of molecular interactions in the coagulation network. While parametric uncertainty can be partially overcome by sampling feasible parameter regions using one of several strategies, structural uncertainty remains a critical determinant of our ability to classify mechanisms as fragile or robust in networks relevant to human health. The mathematical model was further extended to describe platelet activation by other agonists besides thrombin and the intrinsic pathway in Chapter 4. An ensemble of probable parameter sets were estimated using nine experimental data sets from a cell-based model and then used to predict the thrombin generation in experiments using patient-derived plasma for coronary artery and hemophilia A patients. In Chapter 5, analysis of the sensitivity results discloses that the intrinsic protease factor XI could be an excellent therapeutic target for thrombosis treatment with the advantage of not affecting hemostasis. Chapter 6 describes the effect of flow on the initiation of arterial clotting under conditions of exposed tissue factor (TF). Thresholds in shear rates or TF patch sizes were observed for the initiation of clot formation; the balance between the generation of active factors and the removal of those factors by flow was possibly the reason for the threshold phenomena

    Recent advances on mixed metal sulfides for advanced sodium-ion batteries

    No full text
    Sodium-ion batteries (SIBs) have drawn enormous attention in the past few years from both academic and industrial battery communities in view of the fascinating advantages of rich abundance and low cost of sodium resources. Among various electrode materials, mixed metal sulfides (MMSs) stand out as promising negative electrode materials for SIBs considering their superior structural and compositional advantages, such as decent electrochemical reversibility, high electronic conductivity, and rich redox reactions. Here, a summary of some recent developments in the rational design and synthesis of various kinds of MMSs with tailorable architectures, structural/compositional complexity, controllable morphologies, and enhanced electrochemical properties is presented. The effect of structural engineering and compositional design of MMSs on the sodium storage properties is highlighted. It is anticipated that further innovative works on the material design of advanced electrodes for batteries can be inspired.Ministry of Education (MOE)National Research Foundation (NRF)Accepted versionX. W. L. acknowledges the funding support from the National Research Foundation (NRF) of Singapore via the NRF investigatorship (NRF-NRFI2016-04) and Ministry of Education of Singapore via the Academic Research Fund (AcRF) Tier-1 Funding (RG116/18)

    Fabrication of CdS frame-in-cage particles for efficient photocatalytic hydrogen generation under visible-light irradiation

    No full text
    The design of advanced structures for semiconductor photocatalysts is an effective approach to enhance their performance toward solar‐to‐chemical energy conversion. Hollow and frame‐like structures show advantageous features for photocatalytic reactions with enlarged surface area, shortened charge‐transfer distance, promoted light‐absorption ability, and enhanced mass‐transfer capability. Here, a facile two‐step sulfidation strategy is developed to fabricate unique CdS frame‐in‐cage particles for photocatalytic hydrogen generation. Cd‐based Prussian blue analog (Cd‐PBA) cubes are first converted to Cd‐PBA cube‐in‐CdS cage particles, which are further transformed to CdS frame‐in‐cage particles. Benefiting from the novel frame‐in‐cage structure, the obtained CdS photocatalyst exhibits high activity under visible‐light irradiation with the hydrogen generation rate of 13.6 mmol h−1 g−1, which is much enhanced compared with those of the CdS cubes and cages.Ministry of Education (MOE)National Research Foundation (NRF)Accepted versionX.W.L. acknowledges the funding support from the Ministry of Education of Singapore through the AcRF Tier-2 grant (MOE2017-T2-2-003), and the National Research Foundation (NRF) of Singapore via the NRF Investigatorship (NRF-NRFI2016-04)
    corecore